New study to assess maternal health supply market in Sub-Saharan Africa

22nd July 2023

The RHSC, through the Compass initiative, has commissioned US Pharmacopoeia to conduct a study on the regional manufacturing capacity and corresponding market in sub-Saharan Africa (SSA) for oxytocin, misoprostol, magnesium sulphate, tranexamic acid, and heat stable carbetocin. A landscape analysis is currently underway of the existing regional manufacturing capacity and estimated market size of these products in SSA. The study will also assess the gaps and challenges affecting the manufacture of high-quality maternal health supplies in Africa, and identify actions and resources required to address these gaps and challenges. This resource is due to be released later this year and will feature in our upcoming General Membership Meeting. For more information, contact Senior Technical Officer Safia Ahsan at

You are currently offline. Some pages or content may fail to load.